Basel, Basel, Switzerland
Inspiring leader and creative entrepreneur passionate about turning Food and AgTech Innovations into highly successful sustainable businesses. Outstanding knowledge about the international Agro Industry dynamics with a 20-year track record in closing strategic deals with AgTech innovators and large Agriculture corporations. Led international teams from 30 to 300 in 10 different countries in a broad range of businesses focusing on creating a collaborative and outperforming culture.
Generare is unlocking nature’s untapped potential, translating the complexity of microbial DNA into a scalable platform that can transform drug and active ingredient discovery.
Founded in 2010, Amoéba is a biotech based in Chassieu (Lyon, France), leveraging a unique microbial platform with the ambition to become a major player in crop protection and cosmetic sectors.
Advising and mentoring start-ups/scale-ups and executive teams on business and growth strategy Providing guidance and advice for investment strategy to investment groups from early stage to pre-IPO Sustainability strategy and implementation Non-executive director
Bringing protein-based biocontrol to market to shape the future of safe and sustainable food protection Led strategy development for R&D, Regulatory Business Development and commercialization of Biotalys technology Developed growth strategy from 30 to 90 employees, including executive team and internationalization Drove ESG strategy development, corporate governance and policies in line with public requirements Raised >€100m over 4 years in private funding, IPO listing and grants from diverse groups of investors including family offices, institutional investors, banks, private equity, etc Designed and implemented Biotalys IPO in 2021 on Euronext Brussels, working with and extended team of bankers, lawyers, advisors and regulators Led strategic business development initiatives in partnerships (Syngenta, Gates foundation, Novozymes) as well as special M&A projects